AAAAAA
Results: 151-175/688
Authors:
POIRIER JM
HARDY S
ISNARD F
TILLEUL P
WEISSENBURGER J
CHEYMOL G
Citation: Jm. Poirier et al., PLASMA ITRACONAZOLE CONCENTRATIONS IN PATIENTS WITH NEUTROPENIA - ADVANTAGES OF A DIVIDED DAILY DOSAGE REGIMEN, Therapeutic drug monitoring, 19(5), 1997, pp. 525-529
Authors:
KOPECKY EA
JACOBSON S
KLEIN J
KAPUR B
KOREN G
Citation: Ea. Kopecky et al., CORRELATION OF MORPHINE-SULFATE IN BLOOD-PLASMA AND SALIVA IN PEDIATRIC-PATIENTS, Therapeutic drug monitoring, 19(5), 1997, pp. 530-534
Authors:
SPINA E
ARENA D
SCORDO MG
FAZIO A
PISANI F
PERUCCA E
Citation: E. Spina et al., ELEVATION OF PLASMA CARBAMAZEPINE CONCENTRATIONS BY KETOCONAZOLE IN PATIENTS WITH EPILEPSY, Therapeutic drug monitoring, 19(5), 1997, pp. 535-538
Authors:
YUE QY
ALM C
SVENSSON JO
SAWE J
Citation: Qy. Yue et al., QUANTIFICATION OF THE O-DEMETHYLATED AND N-DEMETHYLATED AND THE GLUCURONIDATED METABOLITES OF CODEINE RELATIVE TO THE DEBRISOQUINE METABOLIC RATIO IN URINE IN ULTRARAPID, RAPID, AND POOR DEBRISOQUINE HYDROXYLATORS, Therapeutic drug monitoring, 19(5), 1997, pp. 539-542
Authors:
DALEN P
FRENGELL C
DAHL ML
SJOQVIST F
Citation: P. Dalen et al., QUICK ONSET OF SEVERE ABDOMINAL-PAIN AFTER CODEINE IN AN ULTRARAPID METABOLIZER OF DEBRISOQUINE, Therapeutic drug monitoring, 19(5), 1997, pp. 543-544
Authors:
DEMEDTS P
WYNGAERD AV
WAUTERS A
NEELS H
Citation: P. Demedts et al., MEASUREMENT OF LOW SERUM METHOTREXATE CONCENTRATIONS WITH THE SYVA-EMIT METHOTREXATE ASSAY, Therapeutic drug monitoring, 19(5), 1997, pp. 545-546
Citation: ABSTRACTS - FIFTH INTERNATIONAL-CONGRESS OF THERAPEUTIC DRUG-MONITORING AND CLINICAL TOXICOLOGY - VANCOUVER, CANADA NOVEMBER 10-14, 1997, Therapeutic drug monitoring, 19(5), 1997, pp. 547-606
Authors:
YASUI N
OTANI K
OHKUBO T
OSANAI T
SUGAWARA K
CHIBA K
ISHIZAKI T
KANEKO S
Citation: N. Yasui et al., SINGLE-DOSE PHARMACOKINETICS AND PHARMACODYNAMICS OF ORAL TRIAZOLAM IN RELATION TO CYTOCHROME P4502C19 (CYP2C19) ACTIVITY, Therapeutic drug monitoring, 19(4), 1997, pp. 371-374
Authors:
JOHNSTON A
KEOWN PA
HOLT DW
Citation: A. Johnston et al., SIMPLE BIOEQUIVALENCE CRITERIA - ARE THEY RELEVANT TO CRITICAL DOSE DRUGS - EXPERIENCE GAINED FROM CYCLOSPORINE, Therapeutic drug monitoring, 19(4), 1997, pp. 375-381
Authors:
WELCH J
LENNARD L
MORTON GCA
LILLEYMAN JS
Citation: J. Welch et al., PHARMACOKINETICS OF MERCAPTOPURINE - PLASMA DRUG AND RED-CELL METABOLITE CONCENTRATIONS AFTER AN ORAL DOSE, Therapeutic drug monitoring, 19(4), 1997, pp. 382-385
Authors:
SKOPP G
POTSCH L
Citation: G. Skopp et L. Potsch, A CASE-REPORT ON DRUG SCREENING OF NAIL CLIPPINGS TO DETECT PRENATAL DRUG EXPOSURE, Therapeutic drug monitoring, 19(4), 1997, pp. 386-389
Authors:
ELYAZIGI A
EZZAT A
Citation: A. Elyazigi et A. Ezzat, PHARMACOKINETIC MONITORING OF ANTICANCER DRUGS AT KING-FAISAL-SPECIALIST-HOSPITAL, RIYADH, SAUDI-ARABIA, Therapeutic drug monitoring, 19(4), 1997, pp. 390-393
Authors:
DETOLEDO JC
TOLEDO C
DECERCE J
RAMSAY RE
Citation: Jc. Detoledo et al., CHANGES IN BODY-WEIGHT WITH CHRONIC, HIGH-DOSE GABAPENTIN THERAPY, Therapeutic drug monitoring, 19(4), 1997, pp. 394-396
Authors:
BRATTSTROM C
SAWE J
TYDEN G
HERLENIUS G
CLAESSON K
ZIMMERMAN J
GROTH CG
Citation: C. Brattstrom et al., KINETICS AND DYNAMICS OF SINGLE ORAL DOSES OF SIROLIMUS IN 16 RENAL-TRANSPLANT RECIPIENTS, Therapeutic drug monitoring, 19(4), 1997, pp. 397-406
Authors:
MIZUNO A
UEMATSU T
ISHIKAWA T
YOSHIMINE N
NAKASHIMA M
Citation: A. Mizuno et al., CLINICAL OUTCOME OF SMOKING-CESSATION TRIAL OF NICOTINE CHEWING GUM EVALUATED BY ANALYSIS OF NICOTINE IN HAIR, Therapeutic drug monitoring, 19(4), 1997, pp. 407-412
Authors:
MAHMOOD I
CHAMBERLIN N
TAMMARA V
Citation: I. Mahmood et al., A LIMITED SAMPLING APPROACH IN BIOEQUIVALENCE STUDIES, Therapeutic drug monitoring, 19(4), 1997, pp. 413-419
Authors:
TSANACLIS LM
WILSON JF
Citation: Lm. Tsanaclis et Jf. Wilson, COMPARISON BY EXTERNAL QUALITY ASSESSMENT OF PERFORMANCE OF ANALYTICAL SYSTEMS FOR MEASUREMENT OF THERAPEUTIC DRUGS IN SERUM, Therapeutic drug monitoring, 19(4), 1997, pp. 420-426
Authors:
BAILEY DN
Citation: Dn. Bailey, EFFECT OF DRUGS AND COCAINE METABOLITES ON COCAINE AND COCAETHYLENE BINDING TO HUMAN SERUM IN-VITRO, Therapeutic drug monitoring, 19(4), 1997, pp. 427-430
Authors:
HART AP
MAZARRPROO S
BLACKWELL W
DASGUPTA A
Citation: Ap. Hart et al., A RAPID COST-EFFECTIVE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC (HPLC)ASSAY OF SERUM LAMOTRIGINE AFTER LIQUID-LIQUID-EXTRACTION AND USING HPLC CONDITIONS ROUTINELY USED FOR ANALYSIS OF BARBITURATES, Therapeutic drug monitoring, 19(4), 1997, pp. 431-435
Authors:
OMAR G
WHITING PH
HAWKSWORTH GM
HUMPHREY MJ
BURKE MD
Citation: G. Omar et al., KETOCONAZOLE AND FLUCONAZOLE INHIBITION OF THE METABOLISM OF CYCLOSPORINE-A BY HUMAN LIVER IN-VITRO, Therapeutic drug monitoring, 19(4), 1997, pp. 436-445
Authors:
HUUPPONEN R
HIRVISALO EL
NEUVONEN P
Citation: R. Huupponen et al., COMPARISON OF CYCLOPHILIN BINDING ASSAY AND RADIOIMMUNOASSAY IN MONITORING OF BLOOD CYCLOSPORINE, Therapeutic drug monitoring, 19(4), 1997, pp. 446-449
Authors:
JELLIFFE RW
GOMIS P
TAHANI B
RUSKIN J
SATTLER FR
Citation: Rw. Jelliffe et al., A POPULATION PHARMACOKINETIC MODEL OF TRIMETHOPRIM IN PATIENTS WITH PNEUMOCYSTIS PNEUMONIA, MADE WITH PARAMETRIC AND NONPARAMETRIC METHODS, Therapeutic drug monitoring, 19(4), 1997, pp. 450-459
Authors:
WATELLE M
DEMEDTS P
FRANCK F
DEDEYN PP
WAUTERS A
NEELS H
Citation: M. Watelle et al., ANALYSIS OF THE ANTIEPILEPTIC PHENYLTRIAZINE COMPOUND LAMOTRIGINE USING GAS-CHROMATOGRAPHY WITH NITROGEN PHOSPHORUS DETECTION, Therapeutic drug monitoring, 19(4), 1997, pp. 460-464
Authors:
DATTA P
DASGUPTA A
Citation: P. Datta et A. Dasgupta, INTERFERENCE OF OLEANDRIN AND OLEANDRIGENIN IN DIGITOXIN IMMUNOASSAYS- MINIMAL CROSS-REACTIVITY WITH A NEW MONOCLONAL CHEMILUMINESCENT ASSAY AND HIGH CROSS-REACTIVITY WITH THE FLUORESCENCE POLARIZATION ASSAY, Therapeutic drug monitoring, 19(4), 1997, pp. 465-469
Authors:
ZHANG QL
SIMPSON J
ABOLENEEN HI
Citation: Ql. Zhang et al., A SPECIFIC METHOD FOR THE MEASUREMENT OF TACROLIMUS IN HUMAN WHOLE-BLOOD BY LIQUID-CHROMATOGRAPHY TANDEM MASS-SPECTROMETRY, Therapeutic drug monitoring, 19(4), 1997, pp. 470-476